IL17A and myasthenia gravis: Reduced expressions of Treg markers (e.g., FoxP3 and IL-10) cause Treg dysfunction and are reported to be associated with increased levels of proinflammatory cytokines, IL-6, IL-17 in MG patients, and IFN-γ (46, 58).